Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) ...
Oct 25, 2024
0
0